US-based biotechnology company Carisma Therapeutics has reported findings from a Phase I clinical trial of CT-0508 for the treatment of advanced/metastatic human epidermal growth factor […]
Carisma Therapeutics reports results from cancer therapy trial Read More »
Biotechnology company ABM Therapeutics has dosed the first patient in its Phase I study to evaluate ABM-1310 in patients with relapsed and drug-resistant primary malignant
ABM Therapeutics doses first patient in brain tumour drug trial Read More »
On 24 August, Exelixis announced the early suspension of the double-blinded Phase III CABINET pivotal trial evaluating Exelixis’s Cabometyx (cabozantinib) for patients with progressive, well-differentiated
Exelixis’s Cabometyx Phase III trial sparks hope for pancreatic NET patients Read More »
Scientists have discovered great potential in an up-and-coming drug that targets an aggressive form of brain cancer. Called diffuse midline gliomas (DMGs), these deep-rooted brain tumors often develop
New Drug Can Help Treat Aggressive, Deep-Rooted Brain Tumors Read More »
For many, Kencur ginger is simply an aromatic addition to their culinary repertoire, adding a unique twist to various dishes. For others, it’s a tried-and-true
Anti-cancer effects discovered in Kencur ginger that could revolutionize treatment Read More »
Researchers from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI), the University of Cambridge’s Department of Haematology and the Instituto de Investigación Sanitaria del Principado de
UK researchers develop new test for myeloid leukaemia cancers Read More »
Akeso has dosed the first patient in a head-to-head Phase III trial of ivonescimab to treat locally advanced or metastatic squamous non-small cell lung cancer
Akeso doses first patient in non-small cell lung cancer therapy trial Read More »
Anew Israeli study could open the door to more efficient treatment of certain types of lung cancer, and the prevention of a relapse of illness.
Israeli study may open door to preventing relapse of certain types of lung cancer Read More »
Immatics has initiated a Phase I/II clinical trial evaluating its proprietary Bispecific T cell engaging receptor (TCER) IMA402 in patients with advanced solid tumours. The
Immatics initiates trial of advanced solid tumour therapy Read More »
Researchers at City of Hope, one of the largest cancer research and treatment organisations in the US, are developing a chimeric antigen receptor (CAR) T
City of Hope develops cell therapy for ovarian cancer Read More »
Think of prostate cancer surgery and what likely comes to mind is a radical prostatectomy, which is an operation to remove the entire prostate gland
Prostate cancer: An emerging surgical alternative shows promise in older men Read More »
When it comes to cancer treatments, most people are familiar with chemotherapy, radiation and surgery. Yet there is another emerging, lesser-known therapy that is showing promising
